{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:38:07Z","timestamp":1771659487550,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":546,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ygeno.2020.10.007","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:56:33Z","timestamp":1602867393000},"page":"755-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P2","title":["Comprehensive in-silico analysis of damage associated SNPs in hOCT1 affecting Imatinib response in chronic myeloid leukemia"],"prefix":"10.1016","volume":"113","author":[{"given":"Ismael","family":"Soltani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Bahia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assala","family":"Radhouani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelkarim","family":"Mahdhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salima","family":"Ferchichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ygeno.2020.10.007_bb0005","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","article-title":"Active transport of imatinib into and out of cells: Implications for drug resistance","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/mp050084o","article-title":"Transporters and drug discovery: Why, when, and how","volume":"3","author":"Kim","year":"2006","journal-title":"Mol. Pharm."},{"issue":"17","key":"10.1016\/j.ygeno.2020.10.007_bb0015","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1158\/0008-5472.CAN-06-0769","article-title":"Organic cation transporters are determinants of oxaliplatin cytotoxicity","volume":"66","author":"Zhang","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ygeno.2020.10.007_bb0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.102.034140","article-title":"Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin","volume":"302","author":"Wang","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.ygeno.2020.10.007_bb0025","doi-asserted-by":"crossref","first-page":"F1149","DOI":"10.1152\/ajprenal.00112.2003","article-title":"Functional mapping of rboct1 and rboct2 activity in the s2 segment of rabbit proximal tubule","volume":"285","author":"Kaewmokul","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"Pt 6","key":"10.1016\/j.ygeno.2020.10.007_bb0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1469-1809.2000.6430267.x","article-title":"Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hoct1\/slc22a1)","volume":"63","author":"Hayer","year":"1999","journal-title":"Ann. Hum. Genet."},{"issue":"2\u20133","key":"10.1016\/j.ygeno.2020.10.007_bb0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The slc22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Mol. Asp. Med."},{"issue":"10","key":"10.1016\/j.ygeno.2020.10.007_bb0040","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1073\/pnas.0730858100","article-title":"Pharmacogenetics of membrane transporters I: evolutionary conservation predicts function of variants of the human organic cation transporter","volume":"100","author":"Shu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/clpt.2011.56","article-title":"Genetically polymorphic oct1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol","volume":"90","author":"Tzvetkov","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"18","key":"10.1016\/j.ygeno.2020.10.007_bb0050","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1021\/jm400966v","article-title":"Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2","volume":"56","author":"Hendrickx","year":"2013","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ygeno.2020.10.007_bb0055","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1182\/blood-2006-02-004325","article-title":"Survival benefit with imatinib mesylate versus interferon-alpha-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia","volume":"108","author":"Kantarjian","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ygeno.2020.10.007_bb0060","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1517\/14656566.7.6.721","article-title":"Advances in the treatment for haematological malignancies","volume":"7","author":"Piccaluga","year":"2006","journal-title":"Expert. Opin. Pharmacother."},{"issue":"2\u20133","key":"10.1016\/j.ygeno.2020.10.007_bb0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10142-016-0520-1","article-title":"Regulatory network analysis of micrornas and genes in imatinib-resistant chronic myeloid leukemia","volume":"17","author":"Soltani","year":"2017","journal-title":"Funct. Integr. Genomics"},{"issue":"4","key":"10.1016\/j.ygeno.2020.10.007_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10245332.2016.1252020","article-title":"Downregulation of mir-451 in tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance","volume":"22","author":"Soltani","year":"2017","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.ygeno.2020.10.007_bb0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2002-05-1451","article-title":"Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia","volume":"101","author":"Kantarjian","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ygeno.2020.10.007_bb0080","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood-2005-02-0694","article-title":"Hoct 1 and resistance to imatinib","volume":"106","author":"Crossman","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ygeno.2020.10.007_bb0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00280-017-3266-0","article-title":"Hoct1 gene expression predict for optimal response to imatinib in tunisian patients with chronic myeloid leukemia","volume":"79","author":"Ben Hassine","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"8","key":"10.1016\/j.ygeno.2020.10.007_bb0090","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00008571-200211000-00002","article-title":"Identification of genetic variations of the human organic cation transporter hoct1 and their functional consequences","volume":"12","author":"Kerb","year":"2002","journal-title":"Pharmacogenetics"},{"issue":"3","key":"10.1016\/j.ygeno.2020.10.007_bb0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbrc.2003.11.175","article-title":"Novel single nucleotide polymorphisms of organic cation transporter 1 (slc22a1) affecting transport functions","volume":"313","author":"Sakata","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ygeno.2020.10.007_bb0100","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1210\/jcem-55-5-967","article-title":"Vasoactive intestinal peptide stimulates adrenocorticotropin release from human corticotropinoma cells in culture: Interaction with arginine vasopressin and hydrocortisone","volume":"55","author":"White","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Unit 1","key":"10.1016\/j.ygeno.2020.10.007_bb0105","first-page":"19","article-title":"Searching ncbi\u2019s dbsnp database","volume":"Chapter 1","author":"Bhagwat","year":"2010","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"issue":"Database issue","key":"10.1016\/j.ygeno.2020.10.007_bb0115","first-page":"D190","article-title":"The universal protein resource (uniprot)","volume":"36","author":"UniProt","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.ygeno.2020.10.007_bb0120","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"Sift: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"10.1016\/j.ygeno.2020.10.007_bb0125","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.ygeno.2020.10.007_bb0130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1101\/gr.772403","article-title":"Panther: a library of protein families and subfamilies indexed by function","volume":"13","author":"Thomas","year":"2003","journal-title":"Genome Res."},{"issue":"22","key":"10.1016\/j.ygeno.2020.10.007_bb0135","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/bioinformatics\/btl423","article-title":"Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information","volume":"22","author":"Capriotti","year":"2006","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22225","article-title":"Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden markov models","volume":"34","author":"Shihab","year":"2013","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.ygeno.2020.10.007_bb0145","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/nar\/gkm238","article-title":"Snap: predict effect of non-synonymous polymorphisms on function","volume":"35","author":"Bromberg","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. 3","key":"10.1016\/j.ygeno.2020.10.007_bb0150","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2164-14-S3-S2","article-title":"Collective judgment predicts disease-associated single nucleotide variants","volume":"14","author":"Capriotti","year":"2013","journal-title":"BMC Genomics"},{"issue":"21","key":"10.1016\/j.ygeno.2020.10.007_bb0155","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1093\/bioinformatics\/btp528","article-title":"Automated inference of molecular mechanisms of disease from amino acid substitutions","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"Web Server issue","key":"10.1016\/j.ygeno.2020.10.007_bb0160","doi-asserted-by":"crossref","first-page":"W306","DOI":"10.1093\/nar\/gki375","article-title":"I-mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure","volume":"33","author":"Capriotti","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"10.1016\/j.ygeno.2020.10.007_bb0165","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/bioinformatics\/btv291","article-title":"Inps: Predicting the impact of non-synonymous variations on protein stability from sequence","volume":"31","author":"Fariselli","year":"2015","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.ygeno.2020.10.007_bb0170","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/prot.20810","article-title":"Prediction of protein stability changes for single-site mutations using support vector machines","volume":"62","author":"Cheng","year":"2006","journal-title":"Proteins"},{"issue":"Web Server issue","key":"10.1016\/j.ygeno.2020.10.007_bb0175","doi-asserted-by":"crossref","first-page":"W529","DOI":"10.1093\/nar\/gkq399","article-title":"Consurf 2010: Calculating evolutionary conservation in sequence and structure of proteins and nucleic acids","volume":"38","author":"Ashkenazy","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ygeno.2020.10.007_bb0180","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1006\/jmbi.1996.0226","article-title":"Stability changes upon mutation of solvent-accessible residues in proteins evaluated by database-derived potentials","volume":"257","author":"Gilis","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.ygeno.2020.10.007_bb0185","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/BF02730715","article-title":"Temperature monitoring in newborns using thermospot","volume":"71","author":"Pejaver","year":"2004","journal-title":"Indian J. Pediatr."},{"issue":"548","key":"10.1016\/j.ygeno.2020.10.007_bb0190","article-title":"Protein structure analysis of mutations causing inheritable diseases. An e-science approach with life scientist friendly interfaces","volume":"11","author":"Venselaar","year":"2010","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"10.1016\/j.ygeno.2020.10.007_bb0195","first-page":"681","article-title":"Sopma: Significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments","volume":"11","author":"Geourjon","year":"1995","journal-title":"Comput. Appl. Biosci."},{"issue":"3","key":"10.1016\/j.ygeno.2020.10.007_bb0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nprot.2009.2","article-title":"Protein structure prediction on the web: a case study using the phyre server","volume":"4","author":"Kelley","year":"2009","journal-title":"Nat. Protoc."},{"issue":"Web Server issue","key":"10.1016\/j.ygeno.2020.10.007_bb0205","doi-asserted-by":"crossref","first-page":"W576","DOI":"10.1093\/nar\/gkq535","article-title":"Cphmodels-3.0--remote homology modeling using structure-guided sequence profiles","volume":"38","author":"Nielsen","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"Web Server issue","key":"10.1016\/j.ygeno.2020.10.007_bb0210","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"Swiss-model: Modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ygeno.2020.10.007_bb0215","doi-asserted-by":"crossref","first-page":"W406","DOI":"10.1093\/nar\/gkw336","article-title":"3drefine: An interactive web server for efficient protein structure refinement","volume":"44","author":"Bhattacharya","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.ygeno.2020.10.007_bb0220","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"Ucsf chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"D1","key":"10.1016\/j.ygeno.2020.10.007_bb0225","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"String v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1091\/mbc.e05-05-0402","article-title":"Proteolytic cleavage and phosphorylation of a tumor-associated erbb4 isoform promote ligand-independent survival and cancer cell growth","volume":"17","author":"Maatta","year":"2006","journal-title":"Mol. Biol. Cell"},{"issue":"Web Server issue","key":"10.1016\/j.ygeno.2020.10.007_bb0235","doi-asserted-by":"crossref","first-page":"W510","DOI":"10.1093\/nar\/gkp322","article-title":"Qmean server for protein model quality estimation","volume":"37","author":"Benkert","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.103.053298","article-title":"Pharmacological and physiological functions of the polyspecific organic cation transporters: Oct1, 2, and 3 (slc22a1\u20133)","volume":"308","author":"Jonker","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.ygeno.2020.10.007_bb0245","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.2004.03.050","article-title":"Pharmacokinetics and pharmacodynamics of imatinib in a phase i trial with chronic myeloid leukemia patients","volume":"22","author":"Peng","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygeno.2020.10.007_bb0250","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/sj.clpt.6100087","article-title":"The pharmacogenetics research network: from snp discovery to clinical drug response","volume":"81","author":"Giacomini","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.ygeno.2020.10.007_bb0255","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-07-4913","article-title":"Interaction of imatinib with human organic ion carriers","volume":"14","author":"Hu","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ygeno.2020.10.007_bb0260","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood-2012-01-405035","article-title":"The hoct1 snps m420del and m408v alter imatinib uptake and m420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia","volume":"121","author":"Giannoudis","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ygeno.2020.10.007_bb0265","first-page":"328","article-title":"The c.480c>g polymorphism of hoct1 influences imatinib clearance in patients affected by chronic myeloid leukemia","volume":"14","author":"Di Paolo","year":"2014","journal-title":"Pharm. J."},{"issue":"11","key":"10.1016\/j.ygeno.2020.10.007_bb0270","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/jhg.2010.98","article-title":"Influence of cyp3a5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia","volume":"55","author":"Takahashi","year":"2010","journal-title":"J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.ygeno.2020.10.007_bb0275","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.3109\/10428194.2014.893307","article-title":"Polymorphisms in the human organic cation transporter and the multidrug resistance gene: Correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia","volume":"55","author":"Vine","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0280","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1248\/bpb.34.114","article-title":"Association of slco1b3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia","volume":"34","author":"Nambu","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"12","key":"10.1016\/j.ygeno.2020.10.007_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051771","article-title":"Slc22a1-abcb1 haplotype profiles predict imatinib pharmacokinetics in asian patients with chronic myeloid leukemia","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ygeno.2020.10.007_bb0290","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coph.2017.09.018","article-title":"Cutting GR: transformative therapies for rare cftr missense alleles","volume":"34","author":"Oliver","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"issue":"15","key":"10.1016\/j.ygeno.2020.10.007_bb0295","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1093\/nar\/gky678","article-title":"Performance evaluation of pathogenicity-computation methods for missense variants","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ygeno.2020.10.007_bb0300","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/humu.20938","article-title":"Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods","volume":"30","author":"Thusberg","year":"2009","journal-title":"Hum. Mutat."},{"issue":"6","key":"10.1016\/j.ygeno.2020.10.007_bb0305","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/humu.21490","article-title":"Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed","volume":"32","author":"Hicks","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ygeno.2020.10.007_bb0310","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4951627","article-title":"In silico analysis of coding\/noncoding snps of human retn gene and characterization of their impact on resistin stability and structure","volume":"2019","author":"Elkhattabi","year":"2019","journal-title":"J. Diabetes Res."},{"issue":"2","key":"10.1016\/j.ygeno.2020.10.007_bb0315","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1590\/S1415-47572014005000002","article-title":"Genetic polymorphisms and haplotypes of the organic cation transporter 1 gene (slc22a1) in the xhosa population of South Africa","volume":"37","author":"Jacobs","year":"2014","journal-title":"Genet. Mol. Biol."},{"issue":"2","key":"10.1016\/j.ygeno.2020.10.007_bb0320","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3324\/haematol.2012.066480","article-title":"Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy","volume":"98","author":"Angelini","year":"2013","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.ygeno.2020.10.007_bb0325","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/leu.2015.170","article-title":"Oct1 and imatinib transport in cml: Is it clinically relevant?","volume":"29","author":"Watkins","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.ygeno.2020.10.007_bb0330","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bjh.12591","article-title":"A common novel splice variant of slc22a1 (oct1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia","volume":"163","author":"Grinfeld","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ygeno.2020.10.007_bb0335","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2015.08.034","article-title":"Genetic variations of hoct1 gene and cyp3a4\/a5 genes and their association with imatinib response in chronic myeloid leukemia","volume":"765","author":"Vaidya","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ygeno.2020.10.007_bb0340","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s12032-014-0851-5","article-title":"Reduced abcg2 and increased slc22a1 mrna expression are associated with imatinib response in chronic myeloid leukemia","volume":"31","author":"de Lima","year":"2014","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.ygeno.2020.10.007_bb0345","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/leu.2010.86","article-title":"Hoct1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia","volume":"24","author":"Bazeos","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0350","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsmb882","article-title":"The deltaf508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of cftr","volume":"12","author":"Du","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"34","key":"10.1016\/j.ygeno.2020.10.007_bb0355","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1073\/pnas.1008818107","article-title":"Missense mutations in dystrophin that trigger muscular dystrophy decrease protein stability and lead to cross-beta aggregates","volume":"107","author":"Singh","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ygeno.2020.10.007_bb0360","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J","article-title":"Protein misfolding and degradation in genetic diseases","volume":"14","author":"Bross","year":"1999","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.ygeno.2020.10.007_bb0365","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jmb.2005.12.025","article-title":"Identification and analysis of deleterious human snps","volume":"356","author":"Yue","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.ygeno.2020.10.007_bb0370","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/humu.22","article-title":"Snps, protein structure, and disease","volume":"17","author":"Wang","year":"2001","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.ygeno.2020.10.007_bb0375","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (oct1) on metformin action","volume":"117","author":"Shu","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188143","article-title":"Identification and in silico analysis of functional snps of human tagap protein: a comprehensive study","volume":"13","author":"Arshad","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ygeno.2020.10.007_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000183","article-title":"A catalog of neutral and deleterious polymorphism in yeast","volume":"4","author":"Doniger","year":"2008","journal-title":"PLoS Genet."},{"issue":"21","key":"10.1016\/j.ygeno.2020.10.007_bb0390","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/hmg\/10.21.2319","article-title":"Understanding human disease mutations through the use of interspecific genetic variation","volume":"10","author":"Miller","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ygeno.2020.10.007_bb0395","first-page":"22","article-title":"Effects of oct1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-ht(3) antagonists tropisetron and ondansetron","volume":"12","author":"Tzvetkov","year":"2012","journal-title":"Pharm. J."},{"issue":"5","key":"10.1016\/j.ygeno.2020.10.007_bb0400","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","article-title":"Morphine is a substrate of the organic cation transporter oct1 and polymorphisms in oct1 gene affect morphine pharmacokinetics after codeine administration","volume":"86","author":"Tzvetkov","year":"2013","journal-title":"Biochem. Pharmacol."}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754320319662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754320319662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:25:56Z","timestamp":1760163956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0888754320319662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0888754320319662"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2020.10.007","relation":{},"ISSN":["0888-7543"],"issn-type":[{"value":"0888-7543","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive in-silico analysis of damage associated SNPs in hOCT1 affecting Imatinib response in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2020.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}